144 related articles for article (PubMed ID: 10027904)
1. Cloning of a 2.5 kb murine bone sialoprotein promoter fragment and functional analysis of putative Osf2 binding sites.
Benson MD; Aubin JE; Xiao G; Thomas PE; Franceschi RT
J Bone Miner Res; 1999 Mar; 14(3):396-405. PubMed ID: 10027904
[TBL] [Abstract][Full Text] [Related]
2. Cbfa1 isoform overexpression upregulates osteocalcin gene expression in non-osteoblastic and pre-osteoblastic cells.
Xiao ZS; Hinson TK; Quarles LD
J Cell Biochem; 1999 Sep; 74(4):596-605. PubMed ID: 10440929
[TBL] [Abstract][Full Text] [Related]
3. Analysis of regulator of G-protein signaling-2 (RGS-2) expression and function in osteoblastic cells.
Thirunavukkarasu K; Halladay DL; Miles RR; Geringer CD; Onyia JE
J Cell Biochem; 2002; 85(4):837-50. PubMed ID: 11968023
[TBL] [Abstract][Full Text] [Related]
4. Identification and functional characterization of the human and murine polo-like kinase (Plk) promoter.
Bräuninger A; Strebhardt K; Rübsamen-Waigmann H
Oncogene; 1995 Nov; 11(9):1793-800. PubMed ID: 7478607
[TBL] [Abstract][Full Text] [Related]
5. Identification of a new pebp2alphaA2 isoform from zebrafish runx2 capable of inducing osteocalcin gene expression in vitro.
Pinto JP; Conceição NM; Viegas CS; Leite RB; Hurst LD; Kelsh RN; Cancela ML
J Bone Miner Res; 2005 Aug; 20(8):1440-53. PubMed ID: 16007341
[TBL] [Abstract][Full Text] [Related]
6. Static magnetic fields-induced bone sialoprotein (BSP) expression is mediated through FGF2 response element and pituitary-specific transcription factor-1 motif.
Shimizu E; Matsuda-Honjyo Y; Samoto H; Saito R; Nakajima Y; Nakayama Y; Kato N; Yamazaki M; Ogata Y
J Cell Biochem; 2004 Apr; 91(6):1183-96. PubMed ID: 15048873
[TBL] [Abstract][Full Text] [Related]
7. Characterization of the human topoisomerase IIbeta (TOP2B) promoter activity: essential roles of the nuclear factor-Y (NF-Y)- and specificity protein-1 (Sp1)-binding sites.
Lok CN; Lang AJ; Mirski SE; Cole SP
Biochem J; 2002 Dec; 368(Pt 3):741-51. PubMed ID: 12197834
[TBL] [Abstract][Full Text] [Related]
8. Identification of the promoter of human transcription factor Sp3 and evidence of the role of factors Sp1 and Sp3 in the expression of Sp3 protein.
Lou Z; Maher VM; McCormick JJ
Gene; 2005 May; 351():51-9. PubMed ID: 15857802
[TBL] [Abstract][Full Text] [Related]
9. Transcriptional regulation of the hepatocyte growth factor (HGF) gene by the Sp family of transcription factors.
Jiang JG; Chen Q; Bell A; Zarnegar R
Oncogene; 1997 Jun; 14(25):3039-49. PubMed ID: 9223667
[TBL] [Abstract][Full Text] [Related]
10. An L1 element disrupts human bone sialoprotein promoter: lack of tissue-specific regulation by distalless5 (Dlx5) and runt homeodomain protein2 (Runx2)/core binding factor a1 (Cbfa1) elements.
Kiyoshima T; Yamauchi M; Wong C; Jheon A; Ganss B; Sodek J
Gene; 2002 Oct; 299(1-2):205-17. PubMed ID: 12459268
[TBL] [Abstract][Full Text] [Related]
11. Transcription of the bone sialoprotein gene is stimulated by v-Src acting through an inverted CCAAT box.
Kim RH; Sodek J
Cancer Res; 1999 Feb; 59(3):565-71. PubMed ID: 9973201
[TBL] [Abstract][Full Text] [Related]
12. Functional characterization of the human SOX3 promoter: identification of transcription factors implicated in basal promoter activity.
Kovacevic Grujicic N; Mojsin M; Krstic A; Stevanovic M
Gene; 2005 Jan; 344():287-97. PubMed ID: 15656994
[TBL] [Abstract][Full Text] [Related]
13. Identification of novel protein/DNA interactions within the promoter of the bone-related transcription factor Runx2/Cbfa1.
Drissi H; Pouliot A; Stein JL; van Wijnen AJ; Stein GS; Lian JB
J Cell Biochem; 2002; 86(2):403-12. PubMed ID: 12112009
[TBL] [Abstract][Full Text] [Related]
14. Regulation of GM-CSF gene transcription by core-binding factor.
Cockerill PN; Osborne CS; Bert AG; Grotto RJ
Cell Growth Differ; 1996 Jul; 7(7):917-22. PubMed ID: 8809409
[TBL] [Abstract][Full Text] [Related]
15. Transcriptional autoregulation of the bone related CBFA1/RUNX2 gene.
Drissi H; Luc Q; Shakoori R; Chuva De Sousa Lopes S; Choi JY; Terry A; Hu M; Jones S; Neil JC; Lian JB; Stein JL; Van Wijnen AJ; Stein GS
J Cell Physiol; 2000 Sep; 184(3):341-50. PubMed ID: 10911365
[TBL] [Abstract][Full Text] [Related]
16. Transcriptional regulation of the mouse PNRC2 promoter by the nuclear factor Y (NFY) and E2F1.
Zhou D; Masri S; Ye JJ; Chen S
Gene; 2005 Nov; 361():89-100. PubMed ID: 16181749
[TBL] [Abstract][Full Text] [Related]
17. Identification and characterization of a novel enhancer for the human MCT-1 oncogene promoter.
Shi B; Levenson V; Gartenhaus RB
J Cell Biochem; 2003 Sep; 90(1):68-79. PubMed ID: 12938157
[TBL] [Abstract][Full Text] [Related]
18. GATA-and SP1-binding sites are required for the full activity of the tissue-specific promoter of the tal-1 gene.
Lecointe N; Bernard O; Naert K; Joulin V; Larsen CJ; Romeo PH; Mathieu-Mahul D
Oncogene; 1994 Sep; 9(9):2623-32. PubMed ID: 8058326
[TBL] [Abstract][Full Text] [Related]
19. Transient upregulation of CBFA1 in response to bone morphogenetic protein-2 and transforming growth factor beta1 in C2C12 myogenic cells coincides with suppression of the myogenic phenotype but is not sufficient for osteoblast differentiation.
Lee MH; Javed A; Kim HJ; Shin HI; Gutierrez S; Choi JY; Rosen V; Stein JL; van Wijnen AJ; Stein GS; Lian JB; Ryoo HM
J Cell Biochem; 1999 Apr; 73(1):114-25. PubMed ID: 10088730
[TBL] [Abstract][Full Text] [Related]
20. Tissue- and bone cell-specific expression of bone sialoprotein is directed by a 9.0 kb promoter in transgenic mice.
Paz J; Wade K; Kiyoshima T; Sodek J; Tang J; Tu Q; Yamauchi M; Chen J
Matrix Biol; 2005 Aug; 24(5):341-52. PubMed ID: 15970437
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
